Previous studies have demonstrated PODXL to be a functional ligand of E- and L- selectins in pancreatic cancer suggesting that its expression may promote haemotogenic spread of metastases by facilitating binding of circulating tumour cells to selectin-expressing host cells [22]. This evidence concerns the gene SELL and familial pancreatic carcinoma.